Novartis Globalselect country select business contact A A A Local websites Argentina Australia Austria Bangladesh Belgium Brazil Canada Chile China Colombia Denmark Egypt Finland France Germany Greece Hong Kong Hungary India Indonesia Italy Japan Korea Mexico Netherlands Norway Pakistan Philippines Poland Portugal Russia Slovakia Spain Sweden Switzerland Taiwan Turkey United Kingdom USA Venezuela Businesses Alcon (eye care) CIBA Vision Novartis Animal Health Novartis Diagnostics Novartis Oncology Novartis Vaccines Sandoz (generics) Other websites Novartis Institutes for BioMedical Research Novartis Foundation for Sustainable Development Novartis Malaria Initiative General contact Main switchboard Switzerland +41 61 324 11 11 +41 61 324 80 01 Monday - Friday, 8:30 a.m. - 5:00 p.m. GMT+1 US switchboard +1 862 778 21 00 Monday - Friday, 8:30 a.m. - 5:00 p.m. EST More information Media Global Media Relations Eric Althoff Basel, Switzerland +41 61 324 7999 eric.althoff@novartis.com More information Investors Investor Relations Switzerland investor.relations@novartis.com Monday - Friday, 8:30 a.m. - 5:30 p.m. GMT+1 (Central European Time) Institutional investors Private investors Reporting side effects Report a suspected side effect (also known as an adverse event) related to a Novartis Pharmaceutical drug or a Novartis Vaccine. Reporting side effects pane 4 content Home Products Products home Pharmaceuticals Alcon (eye care) Sandoz (generics) Over-the-Counter Vaccines Animal Health Innovation Innovation home Innovation at Novartis Research and development Focused diversification Getting drugs to patients faster Focus on patient outcomes Innovation for the developing world Responsibly tackling the challenging issues Corporate responsibility Corporate responsibility home Our commitment: improving health Access to healthcare Responsible business practices Metrics and reporting News Resources About Novartis About Novartis home Our mission Healthcare portfolio People Video stories Collaborations Locations Company history Investors Investors home Event calendar Company information Financial results Share data and analysis Shareholder information Fixed-income securities New investors Corporate governance Contacts and services Latest news Newsroom Newsroom home Media releases Featured news Product-related issues Multimedia center Corporate publications Novartis newsrooms Media contacts Stay up-to-date Careers Careers home Job search Culture and values Learning at Novartis Compensation and benefits Diversity and inclusion International BioCamp Careers in research Associate videos Rankings and awards search Fight for Life (Video) Novartis introduces a new short film that captures the passion and commitment of treating some of the world’s most complicated diseases. Read more 26, mar 2014 Featured news: MEDICINES Tackling a Rare Disease: Working Toward a Treatment for SMA Passion and purpose drive the multidisciplinary teams looking for treatments for more than 40 rare diseases, including spinal muscular atrophy. READ MORE Posted: Oct 27, 2013 DISCOVERY 3-D Printing: Scientists Reinvent Research Tools Novartis researchers use 3-D printing to quickly create custom lab equipment to speed drug discovery. READ MORE Posted: Sep 15, 2014 HOPE Long Live Life (Video) We believe that everybody on this fragile planet of ours deserves to live a normal life. We do everything in our power to make this happen. READ MORE Posted: Oct 27, 2013 RECENT STORIES VIDEO MOST POPULAR Long Live Life (Video) Innovative Drug Discovery Speeds New Treatments to Patients (Video) Tackling a Rare Disease: Working Toward a Treatment for SMA Surfing the Wave of Big Data Analytics Protecting Our Tomorrows: Portraits of Meningococcal Disease (Video) Harnessing a Unique Moment in Neuroscience (Video) Cancer: Chronic Care vs. Search for a Cure Novartis announced its results for the second quarter of 2014 on July 17. Visit the event center Watch the webcast What's new 29-Sep-2014 Responding to the Superbug Alarm. Learn more » 18-Sep-2014 No longer living in fear. Learn more » 01-Sep-2014 Dealing with the spread of chronic disease in Africa. Learn more » 30-Aug-2014 Living with heart failure. Learn more » 20-Aug-2014 Novartis provides drug candidate compounds to TB Alliance. Learn more » 15-Jul-2014 Novartis to license Google "smart lens" technology. Learn more » 24-Jun-2014 mHealth: offering a mobile device revolution in healthcare. Learn more » 24-Jun-2014 Novartisclinicaltrials.com, the new home for Novartis-sponsored clinical trial information. Learn more » 18-Jun-2014 Going the final mile against leprosy. Learn more » Visit the featured news archive Subscribe to Novartis featured news Stock chart SIX NYSE NOVZn 89.80 CHF -0.35 (-0.39%) Oct 1, 17:31 CET Stock performance Novartis country websites: Select by country Argentina Australia Austria Bangladesh Belgium Brazil Canada China Denmark Egypt Finland France Germany Greece Hong Kong Hungary India Indonesia Italy Japan Korea Mexico Netherlands Norway Pakistan Philippines Poland Portugal Russia Spain Sweden Switzerland Taiwan Turkey United Kingdom USA go Novartis business websites: Select by business Alcon (eye care) CIBA Vision Novartis Animal Health Novartis Diagnostics Novartis Oncology Novartis Vaccines Sandoz (generics) Novartis Institutes for BioMedical Research Novartis Foundation for Sustainable Development go Worldwide offices Select an office Select an office Follow us Stay up-to-date Receive media releases via e-mail Subscribe to Novartis featured news Receive the Novartis Corporate Responsibility e-newsletter via e-mail © 2014 Novartis AG Terms of usePrivacy policyAbout cookies Sitemap